glp 1 drugs for alcohol GLP-1 Weight Loss and Alcohol: Why Ozempic Reduces Both GLP-1 Anti-Obesity Rx and Alcohol

Landmark trials showed robust weight loss with both semaglutide and tirzepatide

In: StatPearls

doi:10.1016/S0140-6736(17)30058-2 2

The incretin effect was estimated to account for approximately 50% - 70% of the postprandial insulin responses in healthy individuals and may be substantially reduced to 20% 30% in individuals with type 2 diabetes mellitus (T2DM) (6, 7), a complex disorder arising from inadequate compensation of insulin secretion by pancreas to counter peripheral insulin resistance

As the demand for innovative, effective treatments for diabetes and obesity continues to rise, the GLP-1 market is expected to expand further, with new drug approvals and improved treatment options likely to drive continued success